Carino Gurjao’s research focuses on the omics analysis of cancer. He studies a variety of patterns in the tumor genome to better understand the factors that shape these patterns and how they, in turn, can inform clinical decisions. He previously wrote his thesis on the use of so-called “passenger” mutations to treat and prevent cancer.

From Lyon to Paris, via Boston, Carino Gurjao studied at the Institut Curie, MIT, and Harvard (Dana-Farber Cancer Institute and Broad Institute), among other institutions. At the University of Paris, his doctoral thesis demonstrated, for the first time in humans, the mutagenic effect of red meat consumption on colorectal cancer. As a postdoctoral fellow at Columbia University in New York, he led the DNA analysis of the largest cohort of African American patients with colorectal cancer to date. His publication record already includes more than twelve articles published in recognized journals. In 2022, he was named by Forbes as one of the 30 most influential people under 30 in the field of health.